HomePCVX • NASDAQ
add
Vaxcyte Inc
Previous close
$56.21
Day range
$53.24 - $57.90
Year range
$27.66 - $76.61
Market cap
7.86B USD
Avg Volume
1.56M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 274.28M | 69.13% |
Net income | -246.51M | -79.83% |
Net profit margin | — | — |
Earnings per share | -1.80 | -76.89% |
EBITDA | -266.79M | -67.47% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.56B | -10.66% |
Total assets | 3.00B | -14.48% |
Total liabilities | 317.21M | 54.36% |
Total equity | 2.69B | — |
Shares outstanding | 143.92M | — |
Price to book | 2.74 | — |
Return on assets | -22.21% | — |
Return on capital | -23.73% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -246.51M | -79.83% |
Cash from operations | -224.83M | -101.82% |
Cash from investing | 115.12M | 120.66% |
Cash from financing | 2.41M | -50.93% |
Net change in cash | -107.12M | 83.83% |
Free cash flow | -139.25M | -55.65% |
About
Founded
2013
Headquarters
Website
Employees
507
